Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay

Transfusion

Volumn 47, Issue 10, 2007, Pages 1794-1802

  Chevrier, Marie Claire ^a   St Louis, Maryse ^b   Perreault, Josée ^b   Caron, Brigitte ^b   Castilloux, Cindy ^b   Laroche, Jérôme ^b   Delage, Gilles ^b  

^a Recherche et Développement   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN;

ARTICLE; BLOOD DONOR; CANADA; CORRELATION ANALYSIS; DEMOGRAPHY; DNA SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; NUCLEIC ACID ANALYSIS; POLYMERASE CHAIN REACTION; VIRAL S; VIRUS CHARACTERIZATION; VIRUS DETECTION; VIRUS GENE;

AMINO ACID SEQUENCE; BLOOD DONORS; BLOOD SPECIMEN COLLECTION; BLOOD TRANSFUSION; DNA PRIMERS; DNA, VIRAL; GENOTYPE; HEPATITIS B ANTIGENS; HEPATITIS B VIRUS; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMERASE CHAIN REACTION; QUEBEC; RNA, VIRAL;

EID: 34548727462     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01394.x     Document Type: Article

References (49)

1. WHO consultation on international standards for in vitro clinical diagnostic procedures based on nucleic acid amplification techniques (NAT). Geneva : World Health Organization 2002.
2. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis 2002 2 : 395 403.
3. Geneva: World Health Organization 2000. Available from: http://www.who.int/csr/disease/hepatitis/en/
4. Davidson F, Lycett C, Sablon E, Petrik J, Dow BC. Hepatitis B virus genotypes and precore mutations in Scottish blood donors. Vox Sang 2005 88 : 87 92.
5. Hoofnagle JH. Posttransfusion hepatitis B. Transfusion 1990 30 : 384 6.
6. Koziol DE, Holland PV, Alling DW, et al. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med 1986 104 : 488 95.
7. Stevens CE, Aach RD, Hollinger FB, et al. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients: an analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med 1984 101 : 733 8.
8. Alter HJ, Houghton M. Clinical Medical Research Award. Hepatitis C virus and eliminating post-transfusion hepatitis. Nat Med 2000 6 : 1082 6.
9. Kleinman SH, Busch MP. HBV: amplified and back in the blood safety spotlight. Transfusion 2001 41 : 1081 5.
10. Busch MP. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Transfus Clin Biol 2004 11 : 26 32.
11. Lucey C. Brief report on the United States Food and Drug Administration Blood Products Advisory Committee recommendations for management of donors and units testing positive for hepatitis B virus DNA. Vox Sang 2006 91 : 331 5.
12. O'Brien SF, Fan W, Scalia V, Kleinman SH, Vamvakas EC. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services. Transfusion 2007 47 : 316 25.
13. Kuhns MC, Kleinman SH, McNamara AL, et al. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Transfusion 2004 44 : 1332 9.
14. Chaudhuri V, Nanu A, Panda SK, Chand P. Evaluation of serologic screening of blood donors in India reveals a lack of correlation between anti-HBc titer and PCR-amplified HBV DNA. Transfusion 2003 43 : 1442 8.
15. Loeb KR, Jerome KR, Goddard J, Huang M, Cent A, Corey L. High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system. Hepatology 2000 32 : 626 9.
16. Allain JP, Candotti D, Soldan K, et al. The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood 2003 101 : 2419 25.
17. Kleinman SH, Kuhns MC, Todd DS, et al. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion 2003 43 : 696 704.
18. Rozanov M, Plikat U, Chappey C, Kochergin A, Tatusova T. A web-based genotyping resource for viral sequences. Nucleic Acids Res 2004 32 : W654 9.
19. Myers R, Clark C, Khan A, Kellam P, Tedder R. Genotyping Hepatitis B virus from whole- and sub-genomic fragments using position-specific scoring matrices in HBV STAR. J Gen Virol 2006 87 : 1459 64.
20. Rice P, Longden I, Bleasby A. EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet 2000 16 : 276 7.
21. Felsenstein J. PHYLIP - phylogeny interference package (version 3.2). Cladistics 1989 5 : 164 6.
22. Katoh K, Misawa K, Kuma K, Miyata T. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res 2002 30 : 3059 66.
23. Galtier N, Gouy M, Gautier C. SEAVIEW and PHYLO_WIN: two graphic tools for sequence alignment and molecular phylogeny. Comput Appl Biosci 1996 12 : 543 8.
24. Magnius LO, Norder H. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology 1995 38 : 24 34.
25. Yoshikawa A, Gotanda Y, Itabashi M, et al. HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA. Vox Sang 2005 88 : 77 86.
26. Koppelman MH, Zaaijer HL. Diversity and origin of hepatitis B virus in Dutch blood donors. J Med Virol 2004 73 : 29 32.
27. Yotsuyanagi H, Yasuda K, Iino S, et al. HBV DNA in serum of HBsAg-negative, anti-HBc-positive blood donors. Transfusion 2002 42 : 1616 7.
28. Yotsuyanagi H, Yasuda K, Moriya K, et al. Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors. Transfusion 2001 41 : 1093 9.
29. Garcia-Montalvo BM, Farfan-Ale JA, Acosta-Viana KY, Puerto-Manzano FI. Hepatitis B virus DNA in blood donors with anti-HBc as a possible indicator of active hepatitis B virus infection in Yucatan, Mexico. Transfus Med 2005 15 : 371 8.
30. Hennig H, Puchta I, Luhm J, Schlenke P, Goerg S, Kirchner H. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen. Blood 2002 100 : 2637 41.
31. Inaba S, Ito A, Miyata Y, et al. Individual nucleic amplification technology does not prevent all hepatitis B virus transmission by blood transfusion. Transfusion 2006 46 : 2028 9.
32. Kleinman SH, Strong DM, Tegtmeier GG, et al. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Transfusion 2005 45 : 1247 57.
33. Allain JP, Hewitt PE, Tedder RS, Williamson LM. Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion. Br J Haematol 1999 107 : 186 95.
34. Schmidt M, Nubling CM, Scheiblauer H, et al. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests. Vox Sang 2006 91 : 237 43.
35. Bhatti FA, Ullah Z, Salamat N, et al. Anti-hepatitis B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Transfusion 2007 47 : 74 9.
36. Roth WK, Weber M, Petersen D, et al. NAT for HBV and anti-HBc testing increase blood safety. Transfusion 2002 42 : 869 75.
37. Sato S, Ohhashi W, Ihara H, et al. Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay. Transfusion 2001 41 : 1107 13.
38. Comanor L, Holland P. Hepatitis B virus blood screening: unfinished agendas. Vox Sang 2006 91 : 1 12.
39. Biswas R, Tabor E, Hsia CC, et al. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 2003 43 : 788 98.
40. Minegishi K, Yoshikawa A, Kishimoto S, et al. Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening. Vox Sang 2003 84 : 287 91.
41. Weinberger KM, Bauer T, Bohm S, Jilg W. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 2000 81 : 1165 74.
42. Coleman PF. Detecting hepatitis B surface antigen mutants. Emerg Infect Dis 2006 12 : 198 203.
43. Coleman PF, Chen YC, Mushahwar IK. Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol 1999 59 : 19 24.
44. Ireland JH, O'Donnell B, Basuni AA, et al. Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays. Hepatology 2000 31 : 1176 82.
45. Mosley JW, Stevens CE, Aach RD, et al. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion 1995 35 : 5 12.
46. Sayiner AA, Agca H, Sengonul A, et al. A new hepatitis B virus vaccine escape mutation in a renal transplant recipient. J Clin Virol 2007 38 : 157 60.
47. Awerkiew S, Daumer M, Reiser M, et al. Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient. J Clin Virol 2007 38 : 83 6.
48. Soldan K, Ramsay M, Collins M. Acute hepatitis B infection associated with blood transfusion in England and Wales, 1991-7: review of database. BMJ 1999 318 : 95.
49. Echevarria JM, Avellon A. Hepatitis B virus genetic diversity. J Med Virol 2006 78 (Suppl 1 S36 42.